MAPT and Alzheimer disease: Previous studies in cellular and animal models including ours (Levert et al., 2022, in press; Tsujikawa et al., 2022) revealed that upon FLNA overexpression, an increase of tau protein levels and phosphorylation, two events reported in early stages of AD, were observed (Braak et al., 2011).